For patients with relapsed BRCA-mutated ovarian carcinoma, rucaparib produced a median OS of 19.4 months vs 25.4 months with chemotherapy in new findings.

NovoCure's FDA approvals face adoption struggles despite growth. Read why NVCR stock may decline with slow indication ...

Promising preliminary Phase 2b (ASCEND) pancreatic cancer data (Cohort A) reported with Cohort B data anticipated in the coming monthsEnrollment ...

Robust initial efficacy signal with onvansertib + chemo/bev in ongoing first-line RAS-mut metastatic colorectal cancer (“mCRC”) clinical trial (CRDF-004) - - Priced oversubscribed $40 million ...

Improving early detection is one of several holy grails in pancreatic cancer research. Many believe biomarkers — biological ...

An expert explains that the GAP regimen did not improve overall survival in advanced biliary tract cancer versus the doublet ...

Pancreatic cancer reprograms nerve cells to fuel its growth, but blocking these connections can shrink tumors and boost ...

A new study led by researchers at the George Washington University Cancer Center has found that cold therapy, also known as ...

Biosynthesis is the generation of natural products through enzymatic reactions, as in cellular metabolism. Successive enzymatic reactions by a number of enzymes are generally required to achieve a ...

A new study led by a George Washington University Cancer Center researcher found that cold therapy protects breast cancer ...